Back to Journals » Drug Design, Development and Therapy » Volume 17
RETRACTED ARTICLE: Antitumor Effects of Hydromorphone on Human Gastric Cancer Cells in vitro
Authors Liang B, Li C, Zhou Z, Xie Y
Received 21 November 2022
Accepted for publication 22 March 2023
Published 6 April 2023 Volume 2023:17 Pages 1037—1045
DOI https://doi.org/10.2147/DDDT.S398464
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Anastasios Lymperopoulos
This paper has been retracted.
Liang B, Li C, Zhou Z, Xie Y. Drug Des Devel Ther. 2023;17:1037–1045.
We, the Editor and Publisher of the journal Drug Design, Development and Therapy have retracted the published article.
Following publication of the article, concerns were raised about the duplication of images from Figure 4. Specifically,
- Images for Figure 4A, Migration, 0 and 200; 400 and 800; and Invasion, 0 and 400 have been duplicated.
The corresponding author did not respond to our queries and was unable to provide a satisfactory explanation for how the images came to be duplicated or provide satisfactory original data for the study. As verifying the validity of published work is core to the integrity of the scholarly record, the Publisher and Editor requested to retract the article and the corresponding author was notified of this decision.
We have been informed in our decision-making by our editorial policies and COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.